PharmaNutra: New Sales Record in May

The Group shows significant growth in Italy (+20%) and on foreign markets (+ 48%)

PharmaNutra has announced further important results. In May, the Group in fact set a new record for the number of sales compared to the same month in 2017. This significant double-figure growth refers to both the Italian and international markets.

In Italy, sales increased by 20% compared to the same month in 2017, a percentage that is also confirmed by comparing sales relative to the period January-May 2018 with the same period from the previous year (IQVA data plus direct pharmacy orders).

The Group has also considerably improved its sales performance on an international level, with a 48% increase from the beginning of the year, compared to the same period from the previous year.

These results take on even more value when you consider the already consolidated leadership of PharmaNutra in the development of nutraceutical products and innovative medical devices on the Italian market.

Roberto Lacorte, Vice President of PharmaNutra, comments: “These are extremely positive figures that we feel must be communicated to our shareholders in order to involve them in our growth path. The results achieved confirm strengthening of PharmaNutra on the Italian and international market, the direct consequence of research and development activity, one of our important strategic assets in which we intend to continually invest to establish the uniqueness of our products.”